Consulting firm wants cash for helping land studio's 2010 film an Oscar nomination
Oregon man claims "The Next Three Days" depicted him as a fugitive, and now he wants $250K
The dissident shareholder, who's been battling the studio in court, now owns 33.1% of the company
Corporate raider takes hostile takeover bid for studio to the Web
Billionaire investor continues months-long efforts to expand stake in the studio
Billionaire investor says he will buy up $1.6 billion of notes before Spyglass vote
Corporate raider with eyes on indie studio owns stock in both
Chairman Michael Burns reportedly is trying to shape a plan to acquire the studio
The sides had been talking about reaching a settlement, but those talks seem to have stalled
Settlement talks said to include offering him seat on board if Icahn drops takeover bid
Excluding Icahn Group, 70 percent of shares cast in favor of "poison pill" provision
The offer at $7 per share was rejected, the company announced, leaving takeover king to ponder price
British Columbia Court of Appeal allowed company to appeal securities commission's ruling, but then denied appeal
Court will hear the company's side on May 3
'Poison pill' removed; now shareholders can get in on Icahn's $7 offer
Majors and mini-majors stick to the MPAA-led opposition
The price hike includes an open letter to Lions Gate: Our offer is not "coercive"
Letter to shareholders calls the takeover bid "inadequate, coercive"
Forebearance on loans expires at end of March
Studio competing with Lions Gate to acquire killer-robots-from-the-future franchise from bankrupt Halcyon Group
Icahn proxy fight fails to materialize
One Equity Partners, Allen Shapiro get 49 percent stake.
"It’s a step in exerting more forceful control over the destiny of the company. A takeover? not yet. But it’s a step in that direction."
Company acquisition of TV Guide, he said, "borders on recklessness"
